Reuters logo
4 个月内
BRIEF-Neothetics reports last subject enrolled in phase 2 proof of concept trial for lipo-202
2017年3月20日 / 中午12点19分 / 4 个月内

BRIEF-Neothetics reports last subject enrolled in phase 2 proof of concept trial for lipo-202

1 分钟阅读

March 20 (Reuters) - Neothetics Inc:

* Neothetics announces last subject enrolled in phase 2 proof of concept trial for lipo-202 for the reduction of submental subcutaneous fat

* Expects to report top-line data in June 2017 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below